• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

与佩戴电子药物过量检测设备的意愿相关的因素。

Factors associated with willingness to wear an electronic overdose detection device.

机构信息

British Columbia Centre on Substance Use, Vancouver, Canada.

Department of Family Medicine, University of British Columbia, Vancouver, Canada.

出版信息

Addict Sci Clin Pract. 2019 Jul 3;14(1):23. doi: 10.1186/s13722-019-0153-5.

DOI:10.1186/s13722-019-0153-5
PMID:31269963
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6610816/
Abstract

BACKGROUND

North America is in the midst of an opioid overdose epidemic. Although take-home naloxone and other measures have been an effective strategy to reduce overdoses, many events are unwitnessed and mortality remains high amongst those using drugs alone. While wearable devices that can detect and alert others of an overdose are being developed, willingness of people who use drugs to wear such a device has not been described.

METHODS

Drug using persons enrolled in a community-recruited cohort in Vancouver, Canada, were asked whether or not they would be willing to wear a device against their skin that would alert others in the event of an overdose. Logistic regression was used to identify factors independently associated with willingness to wear such a device.

RESULTS

Among the 1061 participants surveyed between December 2017 and May 2018, 576 (54.3%) were willing to wear an overdose detection device. Factors independently associated with willingness included ever having overdosed (adjusted odds ratio [AOR] = 1.39, 95% confidence interval [CI] 1.06-1.83), current methadone treatment (AOR = 1.86, 95% CI 1.45-2.40), female gender AOR = 1.41, 95% CI 1.09-1.84) and a history of chronic pain (AOR = 1.53, 95% CI 1.19-1.96). Whereas homelessness (AOR = 0.67, 95% CI 0.50-0.91) was negatively associated with willingness.

CONCLUSIONS

A high level of willingness to wear an overdose detection device was observed in this setting and a range of factors associated with overdose were positively associated with willingness. Since some factors, such as homelessness may be a barrier, further research is needed to investigate explanations for unwillingness and to evaluate real world acceptability of a wearable overdose detection devices as this technology becomes available.

摘要

背景

北美洲正处于阿片类药物过量流行之中。尽管携带纳洛酮回家和其他措施已成为减少过量的有效策略,但许多事件无人目睹,独自使用毒品的人死亡率仍然很高。虽然正在开发可以检测和提醒他人过量的可穿戴设备,但尚未描述使用毒品的人对佩戴此类设备的意愿。

方法

在加拿大温哥华的一个社区招募的队列中招募了吸毒者,询问他们是否愿意在发生过量时佩戴贴在皮肤上的设备来提醒他人。使用逻辑回归来确定与佩戴此类设备的意愿独立相关的因素。

结果

在 2017 年 12 月至 2018 年 5 月期间调查的 1061 名参与者中,有 576 名(54.3%)愿意佩戴过量检测设备。与愿意佩戴设备独立相关的因素包括曾经过量(调整后的优势比[OR]=1.39,95%置信区间[CI]为 1.06-1.83),当前美沙酮治疗(OR =1.86,95%CI 为 1.45-2.40),女性(OR =1.41,95%CI 为 1.09-1.84)和慢性疼痛史(OR =1.53,95%CI 为 1.19-1.96)。而无家可归(OR =0.67,95%CI 为 0.50-0.91)与佩戴意愿呈负相关。

结论

在这种情况下,观察到对佩戴过量检测设备的高度意愿,并且与过量相关的一系列因素与佩戴意愿呈正相关。由于某些因素(例如无家可归)可能是一个障碍,因此需要进一步研究不愿佩戴的原因,并评估可穿戴式过量检测设备在现实世界中的可接受性,因为这项技术即将面世。

相似文献

1
Factors associated with willingness to wear an electronic overdose detection device.与佩戴电子药物过量检测设备的意愿相关的因素。
Addict Sci Clin Pract. 2019 Jul 3;14(1):23. doi: 10.1186/s13722-019-0153-5.
2
Willingness to use a wearable device capable of detecting and reversing overdose among people who use opioids in Philadelphia.费城使用阿片类药物者对可检测和逆转过量用药的可穿戴设备的使用意愿。
Harm Reduct J. 2021 Jul 23;18(1):75. doi: 10.1186/s12954-021-00522-3.
3
Acceptability of prison-based take-home naloxone programmes among a cohort of incarcerated men with a history of regular injecting drug use.在一组有定期注射吸毒史的被监禁男性中,监狱内带纳洛酮回家方案的可接受性。
Harm Reduct J. 2018 Sep 21;15(1):48. doi: 10.1186/s12954-018-0255-5.
4
Overdose Detection Among High-Risk Opioid Users Via a Wearable Chest Sensor in a Supervised Injecting Facility: Protocol for an Observational Study.通过在监督注射场所使用可穿戴胸部传感器检测高危阿片类药物使用者的药物过量:一项观察性研究方案。
JMIR Res Protoc. 2024 Sep 10;13:e57367. doi: 10.2196/57367.
5
Awareness, Possession, and Use of Take-Home Naloxone Among Illicit Drug Users, Vancouver, British Columbia, 2014-2015.2014 - 2015年,不列颠哥伦比亚省温哥华市非法药物使用者中纳洛酮带回家的知晓、持有及使用情况
Public Health Rep. 2017 Sep/Oct;132(5):563-569. doi: 10.1177/0033354917717230. Epub 2017 Jul 27.
6
High prevalence of non-fatal overdose among people who inject drugs in Malaysia: Correlates of overdose and implications for overdose prevention from a cross-sectional study.马来西亚注射毒品者中非致命性药物过量的高流行率:一项横断面研究中药物过量的相关因素及对药物过量预防的启示
Int J Drug Policy. 2015 Jul;26(7):675-81. doi: 10.1016/j.drugpo.2014.11.010. Epub 2014 Dec 2.
7
What impacts the acceptability of wearable devices that detect opioid overdose in people who use opioids? A qualitative study.什么因素影响了可穿戴设备在使用阿片类药物的人群中检测阿片类药物过量的可接受性?一项定性研究。
Drug Alcohol Rev. 2024 Jan;43(1):213-225. doi: 10.1111/dar.13737. Epub 2023 Aug 19.
8
Determinants of willingness to enroll in opioid agonist treatment among opioid dependent people who inject drugs in Ukraine.乌克兰注射毒品的阿片类药物依赖者中参与阿片类激动剂治疗意愿的决定因素。
Drug Alcohol Depend. 2016 Aug 1;165:213-20. doi: 10.1016/j.drugalcdep.2016.06.011. Epub 2016 Jun 17.
9
Factors associated with willingness to participate in a pharmacologic addiction treatment clinical trial among people who use drugs.吸毒者参与药物成瘾治疗临床试验意愿的相关因素。
Am J Addict. 2015 Jun;24(4):368-73. doi: 10.1111/ajad.12200. Epub 2015 Mar 24.
10
Patient characteristics associated with being offered take home naloxone in a busy, urban emergency department: a retrospective chart review.在繁忙的城市急诊部门,与提供纳洛酮带回家相关的患者特征:回顾性图表审查。
BMC Health Serv Res. 2019 Sep 5;19(1):632. doi: 10.1186/s12913-019-4469-3.

引用本文的文献

1
A protocol for the evaluation of the PneumoWave biosensor in supported accommodation settings: A study on feasibility and acceptability (RESCU-2).一项在支持性住宿环境中评估PneumoWave生物传感器的方案:可行性和可接受性研究(RESCU-2)。
PLoS One. 2025 Jul 7;20(7):e0326482. doi: 10.1371/journal.pone.0326482. eCollection 2025.
2
An implantable system for opioid safety.一种用于阿片类药物安全的可植入系统。
Device. 2024 Oct 18;2(10). doi: 10.1016/j.device.2024.100517. Epub 2024 Aug 14.
3
Overdose Detection Among High-Risk Opioid Users Via a Wearable Chest Sensor in a Supervised Injecting Facility: Protocol for an Observational Study.通过在监督注射场所使用可穿戴胸部传感器检测高危阿片类药物使用者的药物过量:一项观察性研究方案。
JMIR Res Protoc. 2024 Sep 10;13:e57367. doi: 10.2196/57367.
4
Users' Acceptability and Perceived Efficacy of mHealth for Opioid Use Disorder: Scoping Review.移动医疗在阿片类药物使用障碍中的用户可接受性和感知疗效:范围综述。
JMIR Mhealth Uhealth. 2024 Apr 11;12:e49751. doi: 10.2196/49751.
5
Digital Biomarker Applications Across the Spectrum of Opioid Use Disorder.数字生物标志物在阿片类物质使用障碍全谱中的应用
Cogent Ment Health. 2023;2(1). doi: 10.1080/28324765.2023.2240375. Epub 2023 Aug 1.
6
The acceptability of overdose alert and response technologies: introducing the TPOM-ODART framework.过量用药警报和响应技术的可接受性:引入 TPOM-ODART 框架。
Harm Reduct J. 2023 Mar 26;20(1):40. doi: 10.1186/s12954-023-00763-4.
7
Overdose Alert and Response Technologies: State-of-the-art Review.药物过量警报和响应技术:最新综述。
J Med Internet Res. 2023 Feb 15;25:e40389. doi: 10.2196/40389.
8
Overdose Detection Technologies to Reduce Solitary Overdose Deaths: A Literature Review.过量使用检测技术降低独居过量死亡人数:文献综述。
Int J Environ Res Public Health. 2023 Jan 10;20(2):1230. doi: 10.3390/ijerph20021230.
9
Willingness to use a wearable device capable of detecting and reversing overdose among people who use opioids in Philadelphia.费城使用阿片类药物者对可检测和逆转过量用药的可穿戴设备的使用意愿。
Harm Reduct J. 2021 Jul 23;18(1):75. doi: 10.1186/s12954-021-00522-3.
10
Wearable and Wireless mHealth Technologies for Substance Use Disorder.用于物质使用障碍的可穿戴和无线移动健康技术。
Curr Addict Rep. 2020 Sep;7(3):291-300. doi: 10.1007/s40429-020-00318-8. Epub 2020 Jun 11.

本文引用的文献

1
Opioid overdose detection using smartphones.使用智能手机检测阿片类药物过量。
Sci Transl Med. 2019 Jan 9;11(474). doi: 10.1126/scitranslmed.aau8914.
2
Kick LL: A Smartwatch for Monitoring Respiration and Heart Rate using Photoplethysmography.Kick LL:一款使用光电容积脉搏波描记法监测呼吸和心率的智能手表。
Annu Int Conf IEEE Eng Med Biol Soc. 2018 Jul;2018:3821-3824. doi: 10.1109/EMBC.2018.8513356.
3
Opioid Crisis: No Easy Fix to Its Social and Economic Determinants.阿片类危机:社会经济决定因素难以解决。
Am J Public Health. 2018 Feb;108(2):182-186. doi: 10.2105/AJPH.2017.304187. Epub 2017 Dec 21.
4
The Role of Science in Addressing the Opioid Crisis.科学在应对阿片类药物危机中的作用。
N Engl J Med. 2017 Jul 27;377(4):391-394. doi: 10.1056/NEJMsr1706626. Epub 2017 May 31.
5
Supervised injection facilities in Canada: past, present, and future.加拿大的监督注射设施:过去、现在与未来。
Harm Reduct J. 2017 May 18;14(1):28. doi: 10.1186/s12954-017-0154-1.
6
Non-fatal overdose as a risk factor for subsequent fatal overdose among people who inject drugs.非致命性过量用药是注射吸毒者后续发生致命性过量用药的一个风险因素。
Drug Alcohol Depend. 2016 May 1;162:51-5. doi: 10.1016/j.drugalcdep.2016.02.024. Epub 2016 Feb 26.
7
Impact of treatment for opioid dependence on fatal drug-related poisoning: a national cohort study in England.阿片类药物依赖治疗对致命性药物相关中毒的影响:一项在英格兰开展的全国队列研究
Addiction. 2016 Feb;111(2):298-308. doi: 10.1111/add.13193. Epub 2015 Nov 25.
8
Death matters: understanding heroin/opiate overdose risk and testing potential to prevent deaths.死亡至关重要:了解海洛因/阿片类药物过量风险及预防死亡的检测潜力。
Addiction. 2015 Jul;110 Suppl 2:27-35. doi: 10.1111/add.12904.
9
A quantitative and qualitative evaluation of the British Columbia Take Home Naloxone program.不列颠哥伦比亚省纳洛酮带回家计划的定量和定性评估。
CMAJ Open. 2014 Jul 22;2(3):E153-61. doi: 10.9778/cmajo.20140008. eCollection 2014 Jul.
10
Transition to injection drug use: the role of initiators.向注射吸毒的转变:启动因素的作用。
AIDS Behav. 2014 Mar;18(3):486-94. doi: 10.1007/s10461-013-0693-8.